🇺🇸 FDA
Patent

US 7939304

Mutant MT-SP1 proteases with altered substrate specificity or activity

granted A61KA61K38/00

Quick answer

US patent 7939304 (Mutant MT-SP1 proteases with altered substrate specificity or activity) held by Catalyst Biosciences, Inc. expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00